TVTX
Travere Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$4.55B
P/E Ratio
—
EPS
$-0.50
Beta
1.14
52W High
$52.72
52W Low
$13.88
50-Day MA
$41.57
200-Day MA
$32.71
Dividend Yield
—
Profit Margin
-4.00%
Forward P/E
67.11
PEG Ratio
—
About Travere Therapeutics Inc
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development and commercialization of therapies for the treatment of rare diseases. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $536.20M |
| Gross Profit (TTM) | $299.98M |
| EBITDA | $16.09M |
| Operating Margin | -29.00% |
| Return on Equity | -69.40% |
| Return on Assets | -6.46% |
| Revenue/Share (TTM) | $5.95 |
| Book Value | $1.07 |
| Price-to-Book | 46.08 |
| Price-to-Sales (TTM) | 8.48 |
| EV/Revenue | 8.6 |
| EV/EBITDA | 119.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 55.60% |
| Shares Outstanding | $92.99M |
| Float | $86.99M |
| % Insiders | 0.80% |
| % Institutions | 113.34% |
Historical Volatility
HV 10-Day
66.17%
HV 20-Day
56.69%
HV 30-Day
52.09%
HV 60-Day
83.19%
HV Rank
33.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($55.07 target)
2
Strong Buy12
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026